IP Library Granted Patent US 8,969,033
Granted Patent B2
US 8,969,033 · App. 12/655,993 · Granted Mar 3, 2015

Alteration and modulation of protein activity by varying post-translational modification

Inventors: David N. Thompson (Idaho Falls, ID); David W. Reed (Idaho Falls, ID); Vicki S. Thompson (Idaho Falls, ID); Jeffrey A. Lacey (Idaho Falls, ID); William A. Apel (Jackson, WY)
Assignee: Battelle Energy Alliance, LLC
C12N9/1048C12N9/1051C12N9/1288C12P21/00C12P21/005C12Y302/01004C12Y302/01008C12N9/2402C12N9/2437C12N9/2477C12N9/2482
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,969,033
App. No.
12/655,993
Granted
Mar 3, 2015
Kind
B2
Abstract

Embodiments of the invention include methods of altering the enzymatic activity or solubility of an extremophilic enzyme or post-translationally modifying a protein of interest via using isolated or partially purified glycosyltransferases and/or post-translational modification proteins, extracts of cells comprising glycosyltransferases and/or post-translational modification proteins, and/or in cells comprising one or more glycosyltransferases and/or post-translational modification proteins.

Claims (8)

1. A method of altering enzymatic activity of an extremophilic enzyme, the method comprising:

introducing a nucleic acid encoding a polypeptide having at least 90% identity to SEQ ID NO:

307 into Alicyclobacillus acidocaldarius or Pichia pastoris;

allowing the Alicyclobacillus acidocaldarius or Pichia pastoris to express the polypeptide; and

allowing the Alicyclobacillus acidocaldarius or Pichia pastoris to glycosylate the polypeptide;

wherein the glycosylated polypeptide has altered enzymatic activity relative to a non-glycosylated form of the polypeptide; and

wherein the polypeptide has activity as a xylanase.

2. The method according to claim 1 , wherein the glycosylated extremophilic enzyme has altered xylanase activity compared to a non-glycosylated form of the extremophilic enzyme at a pH selected from the group consisting of a pH of less than about 5, about 3.5, and about 2 or at a temperature selected from the group consisting of less than about 90° C., about 90° C., about 80° C., about 70° C., about 60° C., and about 50° C.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 22, 2010
From: BATTELLE ENERGY ALLIANCE, LLC
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 024273/0038 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2010
From: THOMPSON, DAVID N.; REED, DAVID W.; THOMPSON, VICKI S.; LACEY, JEFFREY A.; APEL, WILLIAM A.
To: BATTELLE ENERGY ALLIANCE, LLC
Reel/Frame 023918/0276 →
Continuity (3)
Continuation In Part 12380450 · Feb 26, 2009
Continuation In Part 11266063 · Nov 2, 2005
Related Publication 20100203583A1 · Aug 12, 2010